Modeling Substrate Entry into the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier

被引:3
作者
Jorgensen, Christian [1 ,2 ]
Ulmschneider, Martin B. [3 ]
Searson, Peter C. [1 ,4 ]
机构
[1] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA
[2] Aarhus Univ, Langelandsgade 140, DK-8000 Aarhus, Denmark
[3] Kings Coll London, Dept Chem, London SE1 1DB, England
[4] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
基金
美国国家卫生研究院;
关键词
MOLECULAR-DYNAMICS SIMULATIONS; ATP HYDROLYSIS; MULTIDRUG-RESISTANCE; LATERAL DIFFUSION; PLASMA-MEMBRANE; BINDING; NUCLEOTIDE; TRANSPORT; REVEAL; RHODAMINE-123;
D O I
10.1021/acs.jmedchem.3c01069
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report molecular dynamics simulations of rhodamine entry into the central binding cavity of P-gp in the inward open conformation. Rhodamine can enter the inner volume via passive transport across the luminal membrane or lateral diffusion in the lipid bilayer. Entry into the inner volume is determined by the aperture angle at the apex of the protein, with a critical angle of 27(degrees )for rhodamine. The central binding cavity has an aqueous phase with a few lipids, which significantly reduces substrate diffusion. Within the central binding cavity, we identified regions with relatively weak binding, suggesting that the combination of reduced mobility and weak substrate binding confines rhodamine to enable the completion of the efflux cycle. Tariquidar, a P-gp inhibitor, aggregates at the lower arms of the P-gp, suggesting that inhibition involves steric hindrance of entry into the inner volume and/or steric hindrance of access of ATP to the nucleotide-binding domains.
引用
收藏
页码:16615 / 16627
页数:13
相关论文
共 50 条
  • [21] P-glycoprotein protein expression versus functionality at the blood-brain barrier using immunohistochemistry, microdialysis and mathematical modeling
    De Lange, E. C. M.
    van der Berg, D. J.
    Bellanti, F.
    Voskuyl, R. A.
    Syvanen, S.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 124 : 61 - 70
  • [22] Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier
    Gaillard, PJ
    van der Sandt, ICJ
    Voorwinden, LH
    Vu, D
    Nielsen, JL
    de Boer, AG
    Breimer, DD
    PHARMACEUTICAL RESEARCH, 2000, 17 (10) : 1198 - 1205
  • [23] Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins
    Gimenez, F
    Fernandez, C
    Mabondzo, A
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) : 649 - 658
  • [24] Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier
    Pieter Jaap Gaillard
    Inez Cornelia Johanna van der Sandt
    Levina Helena Voorwinden
    Dung Vu
    Jette Lyngholm Nielsen
    Albertus Gerrit de Boer
    Douwe Durk Breimer
    Pharmaceutical Research, 2000, 17 : 1198 - 1205
  • [25] Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model
    Vulin, Milica
    Zhong, Yu
    Maloney, Bryan J.
    Bauer, Bjoern
    Hartz, Anika M. S.
    FLUIDS AND BARRIERS OF THE CNS, 2023, 20 (01)
  • [26] Blood-Brain Barrier Transport of Naloxone Does Not Involve P-glycoprotein-Mediated Efflux
    Suzuki, Toyofumi
    Miyata, Mariko
    Zaima, Chika
    Furuishi, Takayuki
    Fukami, Toshiro
    Kugawa, Fumihiko
    Tomono, Kazuo
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (01) : 413 - 421
  • [27] On Chip Bioelectric Impedance Spectroscopy Reveals the Effect of P-Glycoprotein Efflux Pumps on the Paracellular Impedance of Tight Junctions at the Blood-Brain Barrier
    Kraya, Ramsey
    Komin, Alexander
    Searson, Peter
    IEEE TRANSACTIONS ON NANOBIOSCIENCE, 2016, 15 (07) : 697 - 703
  • [28] P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
    Schinkel, AH
    Wagenaar, E
    Mol, CAAM
    vanDeemter, L
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2517 - 2524
  • [29] Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine Administration
    Zhao, Rong
    Kalvass, J. Cory
    Yanni, Souzan B.
    Bridges, Arlene S.
    Pollack, Gary M.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 529 - 535
  • [30] Inhibitory Effects of Furanocoumarin Derivatives in Kampo Extract Medicines on P-Glycoprotein at the Blood-Brain Barrier
    Iwanaga, Kazunori
    Yoneda, Shinji
    Hamahata, Yukimi
    Miyazaki, Makoto
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Kakemi, Masawo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) : 1246 - 1251